State Street’s Coya Therapeutics COYA Stock Holding History

State Street’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$314K	Buy	79,813 +10,303	+15%	+$48.2K	﹤0.01%	3767
2025 Q4	$403K	Buy	69,510 +21,410	+45%	+$130K	﹤0.01%	3735
2025 Q3	$274K	Hold	48,100	–	–	﹤0.01%	3816
2025 Q2	$277K	Hold	48,100	–	–	﹤0.01%	3748
2025 Q1	$311K	Hold	48,100	–	–	﹤0.01%	3722
2024 Q4	$276K	Buy	48,100 +5,100	+12%	+$34.7K	﹤0.01%	3776
2024 Q3	$277K	Hold	43,000	–	–	﹤0.01%	3743
2024 Q2	$261K	Sell	43,000 -3,200	-7%	-$25.7K	﹤0.01%	3745
2024 Q1	$458K	Buy	+46,200	New	+$362K	﹤0.01%	3672

Other funds holding COYA

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street's COYA Position: Q1 2026 in Review

State Street increased its Coya Therapeutics (COYA) stake by 15% in Q1 2026, buying an estimated $48.2K and bringing the position to 79,813 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #3767.

State Street first reported a position in COYA in Q1 2024 and has held it in 9 quarters since. The position peaked at $458K in Q1 2024. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

State Street held 79,813 shares of Coya Therapeutics worth $314K as of Q1 2026.
State Street bought 10,303 Coya Therapeutics shares in Q1 2026, an estimated $48.2K.
Coya Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3767 holding.
State Street first reported a position in Coya Therapeutics in Q1 2024 and has held it in 9 quarters since.
State Street's Coya Therapeutics position peaked at $458K in Q1 2024.
56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.